How can men destined for biochemical failure after androgen deprivation and radiotherapy be identified earlier?

D'Ambrosio, David J; Ruth, Karen; Horwitz, Eric M; Uzzo, Robert G; Pollack, Alan; Buyyounouski, Mark K

D'Ambrosio, David J; Ruth, Karen; Horwitz, Eric M; Uzzo, Robert G; Pollack, Alan; Buyyounouski, Mark K.

Affiliation

D'Ambrosio DJ; Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, PA, USA.

Int J Radiat Oncol Biol Phys ; 70(5): 1487-91, 2008 Apr 01.

Article in En | MEDLINE | ID: mdl-18164854

Subject(s)

Androgen Antagonists/therapeutic use; Prostate-Specific Antigen/blood; Prostatic Neoplasms; Aged; Aged, 80 and over; Analysis of Variance; Humans; Male; Middle Aged; Predictive Value of Tests; Proportional Hazards Models; Prostatic Neoplasms/blood; Prostatic Neoplasms/drug therapy; Prostatic Neoplasms/pathology; Prostatic Neoplasms/radiotherapy; Time Factors; Treatment Failure

Fulltext

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms / Prostate-Specific Antigen / Androgen Antagonists Type of study: Prognostic_studies Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Int J Radiat Oncol Biol Phys Year: 2008 Type: Article Affiliation country: United States

Fulltext

XML

PubMed Links

Search on Google